These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 15100431)
1. In vivo activity of nuclease-resistant siRNAs. Layzer JM; McCaffrey AP; Tanner AK; Huang Z; Kay MA; Sullenger BA RNA; 2004 May; 10(5):766-71. PubMed ID: 15100431 [TBL] [Abstract][Full Text] [Related]
2. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing. Bartlett DW; Davis ME Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of nuclease-resistant siRNAs possessing universal overhangs. Ueno Y; Watanabe Y; Shibata A; Yoshikawa K; Takano T; Kohara M; Kitade Y Bioorg Med Chem; 2009 Mar; 17(5):1974-81. PubMed ID: 19200743 [TBL] [Abstract][Full Text] [Related]
4. Introduction of 2-O-benzyl abasic nucleosides to the 3'-overhang regions of siRNAs greatly improves nuclease resistance. Nagaya Y; Kitamura Y; Shibata A; Ikeda M; Akao Y; Kitade Y Bioorg Med Chem Lett; 2017 Dec; 27(24):5454-5456. PubMed ID: 29126849 [TBL] [Abstract][Full Text] [Related]
5. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588 [TBL] [Abstract][Full Text] [Related]
6. Chemical modification of siRNA. Chernolovskaya EL; Zenkova MA Curr Opin Mol Ther; 2010 Apr; 12(2):158-67. PubMed ID: 20373259 [TBL] [Abstract][Full Text] [Related]
7. Solid-phase synthesis of modified RNAs containing amide-linked oligoribonucleosides at their 3'-end and their application to siRNA. Iwase R; Toyama T; Nishimori K Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1451-4. PubMed ID: 18066804 [TBL] [Abstract][Full Text] [Related]
8. Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro. Broering R; Real CI; John MJ; Jahn-Hofmann K; Ickenstein LM; Kleinehr K; Paul A; Gibbert K; Dittmer U; Gerken G; Schlaak JF Int Immunol; 2014 Jan; 26(1):35-46. PubMed ID: 24065781 [TBL] [Abstract][Full Text] [Related]
9. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications. Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579 [TBL] [Abstract][Full Text] [Related]
11. Competition for RISC binding predicts in vitro potency of siRNA. Koller E; Propp S; Murray H; Lima W; Bhat B; Prakash TP; Allerson CR; Swayze EE; Marcusson EG; Dean NM Nucleic Acids Res; 2006; 34(16):4467-76. PubMed ID: 16945958 [TBL] [Abstract][Full Text] [Related]
12. Incorporation of an acyclic alkynyl nucleoside analog into siRNA improves silencing activity and nuclease resistance. Ogata A; Ueno Y Bioorg Med Chem Lett; 2015 Jun; 25(12):2574-8. PubMed ID: 25956414 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis B virus replication in cultured cells and in vivo using 2'-O-guanidinopropyl modified siRNAs. Marimani MD; Ely A; Buff MC; Bernhardt S; Engels JW; Arbuthnot P Bioorg Med Chem; 2013 Oct; 21(20):6145-55. PubMed ID: 23743442 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of modified double stranded RNAs containing duplex regions between amide-linked RNA and RNA at both ends and enhanced nuclease resistance. Iwase R; Kurokawa R; Ueno J Nucleic Acids Symp Ser (Oxf); 2009; (53):119-20. PubMed ID: 19749289 [TBL] [Abstract][Full Text] [Related]
18. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276 [TBL] [Abstract][Full Text] [Related]
19. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Yu JY; DeRuiter SL; Turner DL Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6047-52. PubMed ID: 11972060 [TBL] [Abstract][Full Text] [Related]
20. Use of guanidinopropyl-modified siRNAs to silence gene expression. Buff MC; Bernhardt S; Marimani MD; Ely A; Engels JW; Arbuthnot P Methods Mol Biol; 2015; 1218():217-49. PubMed ID: 25319654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]